The Phylum Bryozoa: From Biology to Biomedical Potential
Less than one percent of marine natural products characterized since 1963 have been obtained from the phylum Bryozoa which, therefore, still represents a huge reservoir for the discovery of bioactive metabolites with its ~6000 described species. The current review is designed to highlight how bryozo...
Main Authors: | Maria Letizia Ciavatta, Florence Lefranc, Leandro M. Vieira, Robert Kiss, Marianna Carbone, Willem A. L. van Otterlo, Nicole B. Lopanik, Andrea Waeschenbach |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/18/4/200 |
Similar Items
-
Ordovician Bryozoa of Estonia
by: Andrej Ernst
Published: (2023-06-01) -
Morphology of Stephanella hina (Bryozoa, Phylactolaemata): common phylactolaemate and unexpected, unique characters
by: Thomas F. Schwaha, et al.
Published: (2020-11-01) -
A new species of Cellaria (Bryozoa: Cheilostomata) from northeastern Brazil, with a tabular identification key to the Atlantic species
by: Ana C.S. Almeida, et al.
Published: (2018-04-01) -
Pharmaceutical Prospects of Bee Products: Special Focus on Anticancer, Antibacterial, Antiviral, and Antiparasitic Properties
by: Firzan Nainu, et al.
Published: (2021-07-01) -
Editorial: Plant chemoecology: Integrating micro- and macrolevel approaches in regulating secondary metabolism
by: Jinya Guo, et al.
Published: (2023-01-01)